Nova Eye Medical (ASX:EYE) – TechKnow Invest Roadshow, August 2023
Tom Spurling - Executive Director - Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Post Views:166
Serving up fresh finance news, marker movers & expertise.
